Menú Close

Artículos sobre Severe acute respiratory syndrome (SARS)

Mostrando 1 - 20 de 110 artículos

In reprioritizing public health, the U.S. limited its ability to respond quickly and effectively to the pandemic. Anton Petrus/Moment via Getty Images

The US was not prepared for a pandemic – free market capitalism and government deregulation may be to blame

While neoliberalism has allowed U.S. markets to grow, the resultant stunted public health system left Americans to figure out how to protect themselves from COVID-19 and its fallout on their own.
A sign in County Kildare, Ireland. in March 2020. Epidemiologists around the world worked hard to try to stop big parties in the face of rising caseloads of what would come to be called COVID-19. Niall Carson/PA Images via Getty Images

Two gaps to fill for the 2021-2022 winter wave of COVID-19 cases

The US was not ready for the coronavirus pandemic in 2020. What can public health leaders and policymakers do to make sure we don’t face another winter of rampant disease?
The Fairmont Royal York Hotel in Toronto. After the SARS pandemic in 2003, Toronto hotels faced a recovery period. (Shutterstock)

SARS didn’t prepare the hospitality industry for the prolonged impact of COVID-19

After SARS in 2003, an effort was made by Toronto’s tourism and hospitality industries to stimulate the sector’s recovery. But measures weren’t put in place for future pandemics.
Is COVID-19 hitting men harder than women? UpperCut Images/Getty Images

Why males may have a worse response to COVID-19

A new study is the first to identify sex differences in inflammation and immune cell activation in response to SARS-CoV-2 infection, which causes COVID-19.
A worker inspects vials of a SARS CoV-2 vaccine for COVID-19 produced by SinoVac at its factory in Beijing on Sept. 24, 2020. (AP Photo/Ng Han Guan)

Training our immune systems: Why we should insist on a high-quality COVID-19 vaccine

Our first exposure to a pathogen, either naturally or via vaccination, can affect how our immune system responds in the future to the same or similar pathogens.
Moderna just released the results of a phase 1 trial for a COVID-19 vaccine. JOSEPH PREZIOSO/AFP via Getty Images

What the phase 1 trials of the first COVID-19 vaccine really mean

Results from phase 1 trials of a COVID-19 mRNA vaccine created a burst of optimism. But details the company failed to release suggest it is too early to speculate whether the vaccine is effective.

Principales colaboradores

Más